PeopleBio Inc (304840) Fair Value & Analysis
Healthcare · KR · Market cap 21.3B KRW
Risks
Fair value as of: Aug 13, 2026
From 1 valuation models · updated 7 days ago
Fair value updated Aug 13, 2026, revised from 905.70 KRW to 504.98 KRW (−44.2%) since Jul 22, 2026. Share price −31.0% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (376.85 KRW to 753.70 KRW) leaves room in how you read the outcome.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 561.00 KRW – 19,887 KRW · fair‑value band 376.85 KRW – 753.70 KRW · the 561.00 KRW price screens above the 504.98 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
PeopleBio Inc (304840) currently trades at 561.00 KRW, while our model-based Fair Value estimate is 504.98 KRW, implying the stock looks roughly 10.0% fairly valued today. The Quality Score stands at 22/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, PeopleBio Inc generated revenue of 3.7B KRW at a net margin of -94.7%. Net debt stands at 7.3B KRW. Fundamentals as of Aug 13, 2026
Our scenario range runs from 376.85 KRW (bear case) to 753.70 KRW (bull case); at 561.00 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -26% fair-value upside, at -10%, 304840 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 304840 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 25 · Market factors (momentum, volatility) 10
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PeopleBio, Inc., a biotech company, engages in developing diagnostics for protein misfolding diseases worldwide. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases.
Full company description
PeopleBio, Inc., a biotech company, engages in developing diagnostics for protein misfolding diseases worldwide. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. The company has strategic collaborations with Seoul National University Bundang Hospital, Etablissement Français du Sang, ADNI Private Partner Scientific Board, Eisai Co., Ltd., Macrogen Corp., ZheJiang Dian Diagnostics Co., Ltd., and LabGenomics, Inc. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PeopleBio Inc reported revenue of 2.9B KRW in FY2025 versus 577M KRW in FY2021, a compound +49.1%/yr. Reported net income was −15.7B KRW in FY2025.
Watch 304840: get an alert when its fair value changes →
Peer Group
Health Care · 2315 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Healthcare Equipment & Supplies” was too small, so the broader sector is used.)
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| InBody Co 041830 | 67,400 KRW | 49,984 KRW | -26% |
| i-SENS, Inc 099190 | 18,480 KRW | 8,168 KRW | -56% |
| Value Added Technology Co 043150 | 20,950 KRW | 60,242 KRW | +188% |
| Mediana Co 041920 | 10,070 KRW | 6,289 KRW | -38% |
| Meta Biomed Co 059210 | 3,980 KRW | 9,268 KRW | +133% |
| Sewoon Medical Co 100700 | 2,300 KRW | 6,054 KRW | +163% |
| MEKICS CO., Ltd 058110 | 1,642 KRW | 1,581 KRW | -4% |
| CU Medical Systems, Inc 115480 | 2,195 KRW | 1,134 KRW | -48% |
| Novartis AG NVSN | 2,742 MXN | 1,952 MXN | -29% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,944 | ₹989.50 | -49% |
Compare PeopleBio Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is PeopleBio Inc (304840) overvalued or undervalued?
What is the fair value of 304840?
What is the quality score of 304840?
What is the revenue of PeopleBio Inc (304840)?
What is the net profit margin of 304840?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PeopleBio Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.